XML 27 R14.htm IDEA: XBRL DOCUMENT v3.25.3

Balance Sheet Components

9 Months Ended

Sep. 30, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Balance Sheet Components

BALANCE SHEET COMPONENTS

Inventory

Inventory consisted of the following (in thousands):

			September 30, 2025						December 31, 2024
Finished goods			$	9,538					$	4,819
Work in progress			5,132						3,793
Raw materials			13,658						10,891
Total inventory			$	28,328					$	19,503

Accrued and Other Liabilities

Accrued and other liabilities consisted of the following (in thousands):

			September 30, 2025						December 31, 2024
Clinical studies			$	14,746					$	16,166
Short-term lease liability			6,432						6,103
Professional fees			6,252						5,971
Deferred revenue			5,763						4,848
Laboratory processing fees and materials			4,748						3,184
Other accrued expenses			6,019						7,080
Total accrued and other liabilities			$	43,960					$	43,352

X

- References

No definition available.

+ Details

Name:	us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 210
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/210/tableOfContent

+ Details

Name:	us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration